This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is a Surprise Coming for Manulife (MFC) This Earnings Season?
by Zacks Equity Research
Manulife (MFC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
MetLife (MET) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
MetLife's (MET) third-quarter results are likely to indicate strong net investment income and sound contributions from segments, partly offset by elevated expenses.
Here's How Investors Can Find Strong Finance Stocks with the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
AON to Announce Q3 Earnings: What's in Store for the Stock?
by Zacks Equity Research
AON's third-quarter results are likely to reflect better revenues and solid performances by its Commercial Risk Solutions, Reinsurance Solutions, Data & Analytic Services and Health Solutions.
What's in Store for Hartford Financial's (HIG) Q3 Earnings?
by Zacks Equity Research
Hartford Financial's (HIG) Q3 earnings results are likely to reflect pressure from the Personal Lines segment, partly offset by contributions from its Commercial Lines, Hartford Funds and Corporate segments.
Can Manulife (MFC) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Manulife (MFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Lincoln National (LNC) is a Good Addition to Your Portfolio
by Zacks Equity Research
Lincoln National (LNC) is poised for growth on the back of an improving economy and solid business fundamentals.
Manulife (MFC) Down 0.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Reasons Why Hold is an Apt Strategy for Manulife (MFC) Stock
by Zacks Equity Research
Growing Asia business, expanding Wealth and Asset Management business, cost savings to improve profitability and solid capital position poise Manulife (MFC) to grow.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Brighthouse (BHF) Q2 Earnings and Revenues Top, Increase Y/Y
by Zacks Equity Research
Brighthouse (BHF) Q2 results reflect sales growth in Annuities and Life.
Manulife (MFC) Q2 Earnings Beat on Solid Segment Results
by Zacks Equity Research
Manulife (MFC) Q2 results reflect higher sales volumes and favorable margins, higher new business gains across all insurance segments and improved retail insurance sales.
Sun Life Financial (SLF) Q2 Earnings Top Estimates, Rise Y/Y
by Zacks Equity Research
Sun Life's (SLF) Q2 results reflect business growth and favorable credit experience, partially offset by unfavorable impacts of foreign exchange translation, lower investing activity and unfavorable expense experience.
Lincoln National (LNC) Q2 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Lincoln National's (LNC) second-quarter results highlight revenue growth, solid segmental performances and reduced mortality impact, partly offset by escalating costs.
Why Manulife (MFC) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Manulife (MFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Manulife Financial (MFC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Lincoln National's (LNC) Solution to Boost Clients' Returns
by Zacks Equity Research
Lincoln National (LNC) launches variable annuity solution Lincoln Investor Advantage Pro in a bid to offer customized protection levels to investors.
Here's Why You Should Retain Voya Financial (VOYA) Stock
by Zacks Equity Research
Voya Financial (VOYA) is poised to benefit from its solid segmental performance, strong capital position and effective capital deployment.
Is Manulife Financial Corp (MFC) a Good Value Investor Stock?
by Zacks Equity Research
Let's see if Manulife Financial Corp (MFC) stock is a good choice for value-oriented investors right now from multiple angles.
Lincoln National's (LNC) Measures to Offer Customized Retirement Plans
by Zacks Equity Research
Lincoln National (LNC) takes initiatives to offer better personalization options for investment plans offered through Morningstar Investment Management's advisor managed accounts service.
7 Insurance Stocks to Bet on Even As Fed Keeps Rates Unchanged
by Tanuka De
In a low interest rate environment, insurers like ALL, MET, HUM, MFC, ORI, HMN, HCI are best investment bets given their fundamental strength.
Prudential (PRU) Unveils Indexed Annuity to Meet Retirement Needs
by Zacks Equity Research
Prudential (PRU) launches FlexGuard Income in a bid to accelerate retirement income growth and offer protection to their assets in case of any market downturn.
Here's Why You Should Retain Athene (ATH) in Your Portfolio
by Zacks Equity Research
Athene (ATH) is well-poised to benefit from higher pension risk transfer premiums, growth in investment portfolio, robust capital position and effective capital deployment.